Trial intelligence / Profile preview

Dexmedetomidine versus morphine for pain control in adult long bone fractures

IRCT20240726062548N1Phase 3Completed

Sponsor
Tehran University of Medical Sciences
Start
Jun 2024
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised trial in Pain due to long bone fracture comparing Morphine with Dexmedetomidine (2 arms). Primary endpoints: Reduction of the pain score, Pain score at 10 minutes and 2 more. Started Jun 2024; status: completed.

02

Drugs

dexmedetomidinemorphine
03

Conditions

Pain due to long bone fracture

Beyond the preview

Go deeper on IRCT20240726062548N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20240726062548N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call